The Role of Vigabatrin in Childhood Seizure Disorders: Results from a Clinical Audit

Summary:  Purpose: The emergence of visual field defects attributed to vigabatrin (VGB) treatment and intramyelinic edema in animal experiments has raised concerns about its future role in the treatment of childhood seizures.

[1]  G. Holmes,et al.  Using the electroretinogram to detect and monitor the retinal toxicity of anticonvulsants , 2000, Neurology.

[2]  G. Krauss.  Using the electroretinogram to detect and monitor the retinal toxicity of anticonvulsants. , 2001, Neurology.

[3]  Wild,et al.  Separating the retinal electrophysiologic effects of vigabatrin. treatment versus field loss , 2000, American journal of ophthalmology.

[4]  G. Krauss,et al.  Visual function loss from vigabatrin. effect Of stopping the drug , 2000 .

[5]  U. Tuor,et al.  Effect of Long‐Term Vigabatrin Administration on the Immature Rat Brain , 2000, Epilepsia.

[6]  Jeffrey A. Cohen,et al.  The Potential for Vigabatrin‐Induced Intramyelinic Edema in Humans , 2000, Epilepsia.

[7]  J. Partanen,et al.  Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects , 1999, Neurology.

[8]  L. Carmant,et al.  ACTH versus vigabatrin therapy in infantile spasms: A retrospective study , 1999, Neurology.

[9]  R. Sankar,et al.  Is the devil we know the lesser of two evils? , 1999, Neurology.

[10]  S. Vanhatalo,et al.  Visual field constriction in children treated with vigabatrin , 1999, Neurology.

[11]  F. Hyder,et al.  GABA Changes with Vigabatrin in the Developing Human Brain , 1999, Epilepsia.

[12]  S. Eisenschenk,et al.  Topographic differences in task-dependent facilitation of magnetic motor evoked potentials , 1999, Neurology.

[13]  J. Osborne,et al.  Topical Review: Vigabatrin in the Treatment of Infantile Spasms in Tuberous Sclerosis: Literature Review , 1999, Journal of child neurology.

[14]  M. Brigell.  Vigabatrin-associated retinal cone system dysfunction , 1998, Neurology.

[15]  L. Carmant,et al.  Role of Vigabatrin and Lamotrigine in Treatment of Childhood Epileptic Syndromes , 1998, Epilepsia.

[16]  C. Hartmann,et al.  Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. , 1998, Archives of ophthalmology.

[17]  A. Palmini,et al.  Vigabatrin in refractory childhood epilepsy. The Brazilian multicenter study , 1997, Epilepsy Research.

[18]  M. Cilio,et al.  Vigabatrin Versus ACTH as First‐Line Treatment for Infantile Spasms: A Randomized, Prospective Study , 1997, Epilepsia.

[19]  M. Brodie,et al.  Severe persistent visual field constriction associated with vigabatrin , 1997, BMJ.

[20]  Josemir W Sander,et al.  Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent. , 1997, BMJ.

[21]  U. Tuor,et al.  Low-Dose Vigabatrin (γ-Vinyl GABA)-Induced Damage in the Immature Rat Brain , 1997, Experimental Neurology.

[22]  T Eke,et al.  Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome , 1997, BMJ.

[23]  U. Tuor,et al.  Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain. , 1997, Experimental neurology.

[24]  R. Mattson,et al.  Human brain GABA levels rise rapidly after initiation of vigabatrin therapy , 1996, Neurology.

[25]  G. Hobbs,et al.  Vigabatrin in childhood epilepsy: comparable efficacy for generalized and partial seizures. , 1996, Clinical neuropharmacology.

[26]  J. Aicardi,et al.  Vigabatrin as Initial Therapy for Infantile Spasms: A European Retrospective Survey , 1996, Epilepsia.

[27]  R. Mattson,et al.  Initial Observations on Effect of Vigabatrin on In Vivo 1H Spectroscopic Measurements of γ‐Aminobutyric Acid, Glutamate, and Glutamine in Human Brain , 1995, Epilepsia.

[28]  B. Hershey,et al.  Use of Ex Vivo Magnetic Resonance Imaging to Detect Onset of Vigabatrin‐Induced Intramyelinic Edema in Canine Brain , 1995, Epilepsia.

[29]  P. Riekkinen,et al.  Vigabatrin (γ‐Vinyl‐GABA): Neuropathologic Evaluation in Five Patients , 1993, Epilepsia.

[30]  C. Loeb,et al.  MRI findings in epileptic patients on vigabatrin for more than 5 years , 1992, Seizure.

[31]  R. Appleton,et al.  Vigabatrin in intractable childhood epilepsy: a retrospective study. , 1992, Pediatric neurology.

[32]  O. Dulac,et al.  Treatment of pediatric epilepsies with gamma-vinyl GABA (vigabatrin). , 1992, Epilepsia.

[33]  O. Dulac,et al.  Vigabatrin in Childhood Epilepsy , 1991, Journal of child neurology.

[34]  O. Dulac,et al.  Therapeutic Trial of Vigabatrin in Refractory Infantile Spasms , 1991, Journal of child neurology.

[35]  W. H. Butler,et al.  Neuropathologic Findings in Patients Receiving Long-Term Vigabatrin Therapy for Chronic Intractable Epilepsy , 1991, Journal of child neurology.

[36]  O. Dulac,et al.  Vigabatrin in the Treatment of Childhood Epilepsies: A Single‐Blind Placebo‐Controlled Study , 1989, Epilepsia.

[37]  S. Trottier,et al.  The neuropathology of vigabatrin. , 1988, British journal of clinical practice. Supplement.

[38]  W. H. Butler,et al.  A Study of the Effects of Vigabatrin on the Central Nervous System and Retina of Sprague Dawley and Lister-Hooded Rats , 1987, Toxicologic pathology.